King of Prussia Company Receives First FDA Pharmaceutical Approval

Nabriva Therapeutics said its drug was the first of its products to be approved by the US Food and Drug Administration, indicating that the drug could now be sold in the United States. It is also the first of a new class of antibiotics introduced in the United States for nearly two decades to treat community acquired bacterial pneumonia, which affects about five million people a year. and is one of the main causes of infection. death linked to the nation, the company said.